Prasugrel tablet bulk supplier for pharma manufacturers

Prasugrel Tablet 5 mg, 10 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 5 mg, 10 mg

Reference Brands: Effient(EU & US)

Prasugrel inhibits the P2Y12 receptor on platelets, preventing ADP-induced activation and aggregation. It rapidly reduces clot formation, lowering the risk of heart attack, stroke, and thrombotic events in acute coronary syndrome patients undergoing PCI. Benefits include quick onset, potent antiplatelet effect, and improved cardiovascular outcomes.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Prasugrel, marketed as Effient, is approved by the FDA in the US and the EMA in the EU for reducing thrombotic events in acute coronary syndrome patients undergoing PCI. Regulatory approval requires a comprehensive dossier with clinical trial data, safety, efficacy, manufacturing, and pharmacovigilance details. In the US, FDA submission involves detailed review, while the EMA's centralized procedure ensures adherence to regional standards. For guidance on dossier preparation, regulatory pathways, and market access strategies, visit PharmaTradz. Ensuring compliance with regional regulations is vital for the successful approval, commercialization, and safe use of prasugrel across global markets.

Prasugrel Tablet — third party manufacturing & bulk supply

Prasugrel Tablet 5 mg, 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Prasugrel Tablet is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Prasugrel Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Prasugrel Tablet →

Back to Listing

Frequently Asked Questions

Prasugrel tablet is listed as Tablet in 5 mg, 10 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Prasugrel tablet is referenced against Effient(EU & US). Reference brands are shown for identification only and remain the property of their respective trademark owners.